Percutaneous Cryoablation of Intercostal Nerves for the Treatment of Rib Fractures

February 5, 2026 updated by: Loma Linda University

The goal of this double blinded randomized control trial is to learn if percutaneous cryoablation of traumatic rib fractures improves outcomes. The main questions it aims to answer are:

Does percutaneous cryoablation improve short and long term pain scores? Does percutaneous cryoablation improve short and long term respiratory mechanics? Does percutaneous cryoablation improve long term quality of life? Does percutaneous cryoablation decrease delirium?

Researchers will compare cryoablation to standard multimodal pain therapy to see if this impacts respiratory recovery.

Participants will undergo randomization, percutaneous cryoablative procedure, and participate in tests at pre-determined intervals to evaluate their pulmonary recovery.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Loma Linda, California, United States, 92354
        • Loma Linda University Health
        • Contact:
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • > 18 years old
  • > 2 rib fractures
  • Verbal Pain score > 5
  • Incentive Spirometry < 60% of predicted

Exclusion Criteria:

  • Isolated Fractures of Ribs 1-3 and/or 10-12
  • Posterior Rib Fracture < 4 cm from costovertebral joint
  • Sternal, Clavicle, Scapula Fracture
  • Thoracic Spinal Fracture of any type
  • Open Abdominothoracic Surgery
  • Unstable Spine
  • Extensive Subcutaneous Emphysema
  • BMI > 35
  • Plan for Rib Plating
  • Chronic Opioid Use
  • Prior to study enrollment: Intubated, Traumatic Brain Injury, Dementia, Cognitive Impairment, Encephalopathy
  • Coagulopathy, Shock at time of ablation
  • Inability to participate in activities of daily living prior to injury
  • Home O2 use prior to trauma
  • Inhalation Injury
  • Rib Fractures due to cardiopulmonary resuscitation
  • Life Expectancy < 6 months
  • > 48 hours from injury
  • Pregnant, Incarcerated

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Single Group Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: Standard multi-modal pain regimen alone
Standard rib fracture protocol including cyclooxygenase inhibitors, anti-neuropathic, muscle relaxers, short term anesthesia interventions (percutaneous block, epidural)
Experimental: Standard multi-modal pain regimen with percutaneous cryoablation
Standard rib fracture protocol including cyclooxygenase inhibitors, anti-neuropathic, muscle relaxers, short term anesthesia interventions (percutaneous block, epidural)
Percutaneous Cryoablation of Intercostal Nerves

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain Score: Numeric Pain Scale
Time Frame: Through study completion, up to 1 year
Short and Long Term Pain Scores. Range from 0 to 10 where 0 is no pain and 10 is most severe and worse outcome.
Through study completion, up to 1 year
Rate of abnormal respiratory mechanics: Incentive Spirometry
Time Frame: Through study completion, up to 1 year
Through study completion, up to 1 year
Rate of abnormal respiratory mechanics: Pulmonary Function Tests
Time Frame: Through study completion, up to 1 year
Short and Long Term Respiratory Mechanics. Pulmonary Function Tests will specifically measure Forced Expiratory Volume in 1 second (FEV1) and Forced Vital Capacity (FVC)
Through study completion, up to 1 year
Rate of delirium: Confusion Assessment Method (CAM) Score
Time Frame: Through study completion, up to 1 year
The score ranges from 0 to 19. Where higher scores indicate more severe delirium and low scores indicate less severe or no delirium
Through study completion, up to 1 year
Quality of Life on Survey
Time Frame: Through study completion, up to 1 year
Long Term Quality of Life
Through study completion, up to 1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rate of Pneumonia
Time Frame: Through study completion, up to 1 year
Through study completion, up to 1 year
Rate of need for Intubation/Mechanical Ventilation
Time Frame: Through study completion, up to 1 year
Through study completion, up to 1 year
Rate of need for tracheostomy
Time Frame: Through study completion, up to 1 year
Through study completion, up to 1 year
Number of Ventilatory Days
Time Frame: Through study completion, up to 1 year
Through study completion, up to 1 year
ICU Length of Stay
Time Frame: Through study completion, up to 1 year
Through study completion, up to 1 year
Hospital Length of Stay
Time Frame: Through study completion, up to 1 year
Through study completion, up to 1 year
Acute Respiratory Distress Syndrome
Time Frame: Through study completion, up to 1 year
Through study completion, up to 1 year
Rate of Mortality
Time Frame: Through study completion, up to 1 year
Through study completion, up to 1 year
Rate of Pleural Space Complications
Time Frame: Through study completion, up to 1 year
Hemothorax, Delayed hemothorax, Pneumothorax, Empyema, Hydrothorax, Rate of tube thoracostomy
Through study completion, up to 1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

September 1, 2026

Primary Completion (Estimated)

July 1, 2028

Study Completion (Estimated)

July 1, 2028

Study Registration Dates

First Submitted

July 30, 2024

First Submitted That Met QC Criteria

July 30, 2024

First Posted (Actual)

August 1, 2024

Study Record Updates

Last Update Posted (Actual)

February 9, 2026

Last Update Submitted That Met QC Criteria

February 5, 2026

Last Verified

February 1, 2026

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Respiratory Failure

Clinical Trials on Multi-modal pain regimen

Subscribe